iScience
(Nov 2018)
KDM5A Regulates a Translational Program that Controls p53 Protein Expression
Dongli Hu,
Carolyn Jablonowski,
Pei-Hsin Cheng,
Alaa AlTahan,
Chunliang Li,
Yingdi Wang,
Lance Palmer,
Cuixia Lan,
Bingmei Sun,
Ahmed Abu-Zaid,
Yiping Fan,
Mark Brimble,
Nicolas T. Gamboa,
Ramhari C. Kumbhar,
David Yanishevski,
Kyle M. Miller,
Guolian Kang,
Gerard P. Zambetti,
Taosheng Chen,
Qin Yan,
Andrew M. Davidoff,
Jun Yang
Affiliations
Dongli Hu
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Carolyn Jablonowski
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Pei-Hsin Cheng
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Alaa AlTahan
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Chunliang Li
Department of Tumor Cell Biology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Yingdi Wang
Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Lance Palmer
Department of Computational Biology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Cuixia Lan
Department of Clinical Laboratory, Affiliated Qingdao Hiser Hospital of Qingdao University, Qingdao 266033, China
Bingmei Sun
Department of Clinical Laboratory, Qingdao Central Hospital, Affiliated Hospital of Qingdao University, Qingdao 266042, China
Ahmed Abu-Zaid
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Yiping Fan
Department of Computational Biology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Mark Brimble
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Nicolas T. Gamboa
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Ramhari C. Kumbhar
Department of Molecular Biosciences, University of Texas at Austin, 100 E 24th St NHB 2.606 Stop A5000, Austin, TX 78712, USA
David Yanishevski
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Kyle M. Miller
Department of Molecular Biosciences, University of Texas at Austin, 100 E 24th St NHB 2.606 Stop A5000, Austin, TX 78712, USA
Guolian Kang
Department of Biostatistics, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Gerard P. Zambetti
Department of Pathology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Taosheng Chen
Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Qin Yan
Department of Pathology, Yale School of Medicine, 310 Cedar St, New Haven, CT 06520, USA
Andrew M. Davidoff
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
Jun Yang
Department of Surgery, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA; Corresponding author
Journal volume & issue
Vol. 9
pp.
84
– 100
Abstract
Read online
Summary: The p53 tumor suppressor pathway is frequently inactivated in human cancers. However, there are some cancer types without commonly recognized alterations in p53 signaling. Here we report that histone demethylase KDM5A is involved in the regulation of p53 activity. KDM5A is significantly amplified in multiple types of cancers, an event that tends to be mutually exclusive to p53 mutation. We show that KDM5A acts as a negative regulator of p53 signaling through inhibition of p53 translation via suppression of a subgroup of eukaryotic translation initiation genes. Genetic deletion of KDM5A results in upregulation of p53 in multiple lineages of cancer cells and inhibits tumor growth in a p53-dependent manner. In addition, we have identified a regulatory loop between p53, miR-34, and KDM5A, whereby the induction of miR-34 leads to suppression of KDM5A. Thus, our findings reveal a mechanism by which KDM5A inhibits p53 translation to modulate cancer progression. : Molecular Mechanism of Gene Regulation; Cancer Subject Areas: Molecular Mechanism of Gene Regulation, Cancer
WeChat QR code
Close